Inclusion criteria: | |
Patients eligible for the trial must comply with all of the following at randomization • Age 18 years or older • Patient with indication (ASGE, Jacobson BC, GIE2005) of drainage of only one typea related to the symptomatology, as a local complication of previous acute pancreatitis • Patient capable of understanding and signing informed consent form • Patient understanding the type of study and complying with the follow-up of complementary tests during the study’s duration | |
Exclusion criteria | |
• Pregnancy or breast-feeding • Severe coagulation disorder: INR > 1.5 not correctible with administration of plasma and/or platelets < 50,000/mm3 • Asymptomatic patients, without clinical indication of drainage, except for those with vascular compression involvement • Non-identification of solid content during EUS procedure • Failure to sign informed consent form • Patients with intellectual handicap who are unable to understand the nature and possible consequences of the study, unless there is a competent legal representative • Patients unable to adhere to subsequent follow-up requirements • Conditions that preclude upper digestive endoscopy, such as stenosis |